Quantcast
Last updated on April 18, 2014 at 17:08 EDT

Latest Oncothyreon Inc. Stories

2013-05-02 08:38:09

SEATTLE, WA, May 2, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, May 9, 2013 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its first quarter 2013 financial results and provide a review of its pipeline of products in development. To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and can be...

2013-03-29 08:22:36

SEATTLE, WA, March 29, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 20(th) Annual Future Leaders in the Biotech Industry Conference, presented by BioCentury and Thomson Reuters, in New York on Friday, April 5, 2013 at 10:30 a.m. Eastern time. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the...

2013-03-14 08:28:48

Company to Hold Conference Call at 8:30 a.m. EST Today SEATTLE, WA, March 14, 2013 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported financial results for the year and quarter ending December 31, 2012. Loss from operations for the year ended December 31, 2012 was $28.5 million, compared with $24.7 million for the year ended December 31, 2011. The increase in loss from operations primarily resulted from an increase in research and development expenses to $22.0 million...

2013-03-07 08:29:27

SEATTLE, WA, March 7, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, March 14, 2013 at 8:30 a.m. Eastern Time to discuss its financial results and provide a review of its pipeline of products in development. To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International).  In addition, the call will be webcast live and can be accessed on the "Events"...

2013-03-01 08:24:24

LONDON, March 1, 2013 /PRNewswire/ -- The Healthcare industry is undergoing a major overhaul after the Supreme Court last year upheld President Obama's Affordable Care Act (ACA). While critics of the healthcare reform say that it increase costs for the healthcare industry, proponents of ACA note that the increase in the number of insured individuals will ultimately benefit the industry. Meanwhile, healthcare companies such as UnitedHealth Group Inc. (NYSE: UNH), Aetna Inc....

2013-02-27 08:29:22

SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Cowen and Company 33(rd) Annual Health Care Conference in Boston on Wednesday, March 6, 2013 at 8 a.m. Eastern. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section. About Oncothyreon Oncothyreon is a...

2012-12-19 08:24:43

Company to Hold Conference Call at 8:30 am EST Today SEATTLE, WA, Dec. 19, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that the pivotal Phase 3 clinical trial of L-BLP25 (formerly referred to as Stimuvax(®)) known as START did not meet its primary endpoint of an improvement in overall survival in patients with unresectable, locally advanced stage IIIA or stage IIIB non-small cell lung cancer (NSCLC).  The trial was conducted by Merck Serono, a...

2012-11-07 16:27:45

Company to Hold Conference Call at 4:30 p.m. EST Today SEATTLE, Nov. 7, 2012 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported financial results for the third quarter ending September 30, 2012. Loss from operations increased in the third quarter of 2012 to $7.7 million from $6.4 million in the third quarter of 2011, and to $21.5 million for the nine months ended September 30, 2012 compared to $18.1 million for the comparable period in 2011. This increase in loss from...

2012-11-07 08:28:18

SEATTLE, Nov. 7, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that management will be presenting at the following upcoming investment conferences in November. Lazard Capital Markets 9th Annual Healthcare Conference Wednesday, November 14, 2012, at 3:00 p.m. Eastern time in New York, NY 24(th) Annual Piper Jaffray Healthcare Conference Tuesday, November 27, 2012, at 3 p.m. Eastern time in New York, NY A live and archived webcast of each presentation will be...

2012-10-31 07:28:21

SEATTLE, WA, Oct. 31, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Wednesday, November 7, 2012 at 4:30 p.m. Eastern Time to discuss its financial results and provide a review of its pipeline of products in development. To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International).  In addition, the call will be webcast live and can be accessed on the "Events"...